BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30516825)

  • 1. Histone demethylase UTX is a therapeutic target for diabetic kidney disease.
    Chen H; Huang Y; Zhu X; Liu C; Yuan Y; Su H; Zhang C; Liu C; Xiong M; Qu Y; Yun P; Zheng L; Huang K
    J Physiol; 2019 Mar; 597(6):1643-1660. PubMed ID: 30516825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation.
    Hung PH; Hsu YC; Chen TH; Ho C; Lin CL
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A KDM6 inhibitor potently induces ATF4 and its target gene expression through HRI activation and by UTX inhibition.
    Kitajima S; Sun W; Lee KL; Ho JC; Oyadomari S; Okamoto T; Masai H; Poellinger L; Kato H
    Sci Rep; 2021 Feb; 11(1):4538. PubMed ID: 33633164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma.
    Lochmann TL; Powell KM; Ham J; Floros KV; Heisey DAR; Kurupi RIJ; Calbert ML; Ghotra MS; Greninger P; Dozmorov M; Gowda M; Souers AJ; Reynolds CP; Benes CH; Faber AC
    Sci Transl Med; 2018 May; 10(441):. PubMed ID: 29769286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histone Demethylase UTX Promotes Brown Adipocyte Thermogenic Program Via Coordinated Regulation of H3K27 Demethylation and Acetylation.
    Zha L; Li F; Wu R; Artinian L; Rehder V; Yu L; Liang H; Xue B; Shi H
    J Biol Chem; 2015 Oct; 290(41):25151-63. PubMed ID: 26306033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone demethylase UTX aggravates acetaminophen overdose induced hepatotoxicity through dual mechanisms.
    Huang Y; Xie Y; Yang D; Xiong M; Chen X; Wu D; Wang Q; Chen H; Zheng L; Huang K
    Pharmacol Res; 2022 Jan; 175():106021. PubMed ID: 34883214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the H3K27 demethylase UTX enhances the epigenetic silencing of HIV proviruses and induces HIV-1 DNA hypermethylation but fails to permanently block HIV reactivation.
    Nguyen K; Dobrowolski C; Shukla M; Cho WK; Luttge B; Karn J
    PLoS Pathog; 2021 Oct; 17(10):e1010014. PubMed ID: 34673825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
    Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
    Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EZH2, JMJD3, and UTX epigenetically regulate hepatic plasticity inducing retro-differentiation and proliferation of liver cells.
    Pediconi N; Salerno D; Lupacchini L; Angrisani A; Peruzzi G; De Smaele E; Levrero M; Belloni L
    Cell Death Dis; 2019 Jul; 10(7):518. PubMed ID: 31285428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effect of the histone demethylase inhibitor GSK-J4 in chondrosarcomas.
    Lhuissier E; Aury-Landas J; Allas L; Boittin M; Boumediene K; Baugé C
    IUBMB Life; 2019 Nov; 71(11):1711-1719. PubMed ID: 31241814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK-J4: An H3K27 histone demethylase inhibitor, as a potential anti-cancer agent.
    Dalpatraj N; Naik A; Thakur N
    Int J Cancer; 2023 Sep; 153(6):1130-1138. PubMed ID: 37165737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of GSK-J4, a histone demethylase KDM6B/JMJD3 inhibitor, for acute myeloid leukemia.
    Li Y; Zhang M; Sheng M; Zhang P; Chen Z; Xing W; Bai J; Cheng T; Yang FC; Zhou Y
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1065-1077. PubMed ID: 29594337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone demethylase Utx regulates differentiation and mineralization in osteoblasts.
    Yang D; Okamura H; Teramachi J; Haneji T
    J Cell Biochem; 2015 Nov; 116(11):2628-36. PubMed ID: 25920016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG.
    Nikolaev A; Fiveash JB; Yang ES
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31940975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization by Histone H3 Demethylase Inhibition in Diffuse Intrinsic Pontine Glioma.
    Katagi H; Louis N; Unruh D; Sasaki T; He X; Zhang A; Ma Q; Piunti A; Shimazu Y; Lamano JB; Carcaboso AM; Tian X; Seluanov A; Gorbunova V; Laurie KL; Kondo A; Wadhwani NR; Lulla R; Goldman S; Venneti S; Becher OJ; Zou L; Shilatifard A; Hashizume R
    Clin Cancer Res; 2019 Sep; 25(18):5572-5583. PubMed ID: 31227500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation.
    Kania AK; Guo M; Scharer CD; Boss JM
    Immunohorizons; 2021 Dec; 5(12):918-930. PubMed ID: 34880105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone H3K27me3 demethylases regulate human Th17 cell development and effector functions by impacting on metabolism.
    Cribbs AP; Terlecki-Zaniewicz S; Philpott M; Baardman J; Ahern D; Lindow M; Obad S; Oerum H; Sampey B; Mander PK; Penn H; Wordsworth P; Bowness P; de Winther M; Prinjha RK; Feldmann M; Oppermann U
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6056-6066. PubMed ID: 32123118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the Histone H3K27 Demethylase UTX Enhances Tumor Cell Radiosensitivity.
    Rath BH; Waung I; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2018 May; 17(5):1070-1078. PubMed ID: 29483212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hsa-miR-199b-3p Prevents the Epithelial-Mesenchymal Transition and Dysfunction of the Renal Tubule by Regulating E-cadherin through Targeting KDM6A in Diabetic Nephropathy.
    Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W
    Oxid Med Cell Longev; 2021; 2021():8814163. PubMed ID: 34257820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways.
    Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY
    J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.